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Paternal repression of the imprinted H19 gene is mediated by a differentially methylated domain (DMD) that is
essential to imprinting of both H19 and the linked and oppositely imprinted Igf2 gene. The mechanisms by which
paternal-specific methylation of the DMD survive the period of genome-wide demethylation in the early embryo and
are subsequently used to govern imprinted expression are not known. Methyl-CpG binding (MBD) proteins are likely
candidates to explain how these DMDs are recognized to silence the locus, because they preferentially bind
methylated DNA and recruit repression complexes with histone deacetylase activity. MBD RNA and protein are found
in preimplantation embryos, and chromatin immunoprecipitation shows that MBD3 is bound to the H19 DMD. To test a
role for MBDs in imprinting, two independent RNAi-based strategies were used to deplete MBD3 in early mouse
embryos, with the same results. In RNAi-treated blastocysts, paternal H19 expression was activated, supporting the
hypothesis that MBD3, which is also a member of the Mi-2/NuRD complex, is required to repress the paternal H19
allele. RNAi-treated blastocysts also have reduced levels of the Mi-2/NuRD complex protein MTA-2, which suggests a
role for the Mi-2/NuRD repressive complex in paternal-specific silencing at the H19 locus. Furthermore, DNA
methylation was reduced at the H19 DMD when MBD3 protein was depleted. In contrast, expression and DNA
methylation were not disrupted in preimplantation embryos for other imprinted genes. These results demonstrate new
roles for MBD3 in maintaining imprinting control region DNA methylation and silencing the paternal H19 allele. Finally,
MBD3-depleted preimplantation embryos have reduced cell numbers, suggesting a role for MBD3 in cell division.
Citation: Reese KJ, Lin S, Verona RI, Schultz RM, Bartolomei MS (2007) Maintenance of paternal methylation and repression of the imprinted H19 gene requires MBD3. PLoS
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Introduction
Genomic imprinting, an epigenetic process resulting in
expression of one parental allele, is an important mechanism
of transcriptional control in mammals [1,2]. Failure of
transcriptional regulation deﬁnes the molecular basis for
many human diseases, emphasizing the importance of this
control for normal growth and development. Accordingly,
loss of imprinting is implicated in a number of human
diseases and cancers. For example, Beckwith-Wiedemann
syndrome, a disorder characterized by overgrowth and tumor
development, results from defects in gene expression from
either of two linked but independently controlled imprinted
gene clusters on 11p15.5, the H19/IGF2 or KCNQ1OT1/
CDKN1C clusters [3].
The mechanism by which imprinted gene expression is
established and maintained has been extensively studied but
still remains incompletely understood. DNA methylation
represents one of the best candidates for conferring
parental-speciﬁc expression patterns because DNA methyl-
ation is differentially acquired in the parental germlines,
maintained following fertilization, and subsequently em-
ployed to silence the nonexpressed allele. One of the best
examples of such regulation is observed at the mouse H19/Igf2
locus [4]. The H19 gene, which encodes a noncoding RNA,
and the Igf2 gene, which encodes a fetal mitogen, are
expressed from opposite parental alleles, but their imprinted
expression is regulated by common DNA elements [5–7]. One
such element is a 2-kb imprinting control region located 2 kb
upstream from the H19 transcriptional start site, designated
the differentially methylated domain (DMD), which is
required for imprinted expression of both H19 and Igf2 [8].
The DMD forms an active CTCF-dependent insulator on the
maternal allele that governs expression of H19 and repression
of Igf2. In the male germline, the DMD acquires methylation
that is necessary for repression of the paternal H19 allele [9–
13]. Methylation of the DMD is essential for imprinted
expression because H19, which is normally maternally ex-
pressed throughout development, is biallelically expressed in
DNA methyltransferase 1 (Dnmt1) mutants [14]. Thus, while
much is known about the sequences required for H19
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ation at this locus, less is known about how DNA methylation
leads to silencing of the paternal allele.
Although CTCF has been shown to bind the unmethylated
DMD on the maternal H19 allele, leading to formation of an
insulator, cofactors that are required for recognition of the
repressed paternal allele have not been identiﬁed. The
methyl-CpG-binding proteins (MBDs) are possible candidates
for the dual jobs of recognizing DNA methylation marks and
silencing transcription from the locus [15]. Biochemical
studies have demonstrated that these proteins can bind
methylated DNA and associate with repressive complexes in
vitro. These proteins may, therefore, provide the link
between DNA methylation and transcriptional silencing at
imprinted loci.
To determine the role of MBDs in imprinted gene
regulation, we have taken an RNAi approach to generate
hypomorphic alleles. Although we and others have found that
transcripts for all Mbd genes are present in early mouse
embryos ([16]; KJR, unpublished data), Mbd3 was chosen as the
ﬁrst target for RNAi because Mbd3 null embryos die early in
embryogenesis, suggesting a critical role in development [17].
Additionally, we have determined that MBD3 is bound to the
H19 DMD. Using both injections of one-cell embryos with
double-stranded RNA (dsRNA) against Mbd3 (dsMbd3) and a
transgenic (TG) RNAi approach that reduces Mbd3 mRNA in
oocytes, we demonstrate that H19 is activated on the
normally methylated and repressed paternal allele in blasto-
cysts with reduced amounts of MBD3 protein. This biallelic
H19 expression in Mbd3 RNAi embryos is signiﬁcantly
different from control embryos, which retain monoallelic
expression. Other imprinted genes analyzed in the Mbd3-
depleted embryos are monoallelically expressed, suggesting
each locus may require a separate MBD partner. Interestingly,
Mbd3 RNAi embryos have reduced DNA methylation at the
H19 locus, but not at the imprinted Snrpn locus, indicating a
critical role for MBD3 in maintaining paternal methylation
marks at the H19 locus during a critical window of genome
wide demethylation. Finally, reducing MBD3 levels affects cell
division and, consequently, the size of RNAi embryos. These
ﬁndings support the hypothesis that MBD proteins are
required for the interpretation and maintenance of allele
speciﬁc methylation marks leading to repression of the
paternal H19 allele.
Results
Temporal and Spatial Pattern of Expression of Mbd3 RNA
and Protein during Preimplantation Development
RT-PCR experiments using Mbd3 speciﬁc primers demon-
strated that Mbd3 RNA is present in oocytes and preimplan-
tation mouse embryos (Figure 1A). The RNA was quantiﬁed
and normalized relative to known amounts of rabbit globin
RNA added prior to RNA preparation. Mbd3 RNA levels are
high in the oocyte, become reduced through early stages of
preimplantation embryogenesis, but rise again by the
blastocyst stage. This proﬁle is consistent with expression of
many other transcripts; degradation of maternal transcripts
followed by replacement at the two-cell stage with zygotic
transcripts. MBD3 protein follows a similar distribution, with
levels highest in the oocyte and blastocyst (Figure 1B).
Interestingly, MBD3 protein is present on the DNA and
spindle in eggs, and is nuclear at all other stages with
punctate foci of stronger staining. As proposed for tran-
scription factors that remain associated with chromosomes
during mitosis and direct transcription following entry into
interphase, MBD39s association with chromatin in eggs may
provide a similar molecular memory to ensure appropriate
marking of the maternal allele. Thus, both Mbd3 RNA and
protein are present at this critical period for imprinted gene
expression when imprints are becoming established.
MBD3 Is Bound Preferentially to the Paternal Allele at the
H19 DMD
To determine if MBD3 is associated with the H19 locus,
chromatin immunoprecipitation (ChIP) experiments were
performed with an MBD3 antibody on C57BL/6 X
B6(CAST7P12X) hybrid embryonic stem (ES) cells (Joanne
Thorvaldsen, MSB, unpublished data). After immunoprecipi-
tation of chromatin, PCR analysis showed that MBD3 was
associated with the H19 DMD, with a slight preferential
association with the methylated paternal allele (Figure 1C).
An antibody against acetylated histone H3 (AcH3) was used as
a control because the 39 end of the DMD was reported to
associate with acetylated histone H3 on the maternal allele
[18]. The region of the DMD reported here showed a similar
preference for the maternal allele (RIV and MSB, unpub-
lished data). Furthermore, MBD3 associates with the Oct4
locus in undifferentiated ES cells [19], a ﬁnding we also
observed, therefore validating our immunoprecipitation
results. Interestingly, MBD3 was not associated with either
allele of the imprinted Snrpn gene (Figure 1C), suggesting a
speciﬁc role for MBD3 at the H19 locus. To conﬁrm that these
results were different from no-primary controls, quantitative
real-time PCR was performed at both the H19 DMD and the
Snrpn imprinting control region for three or more independ-
ent ChIP experiments (Figure 1D). At the H19 locus, MBD3
was signiﬁcantly associated with the locus when compared to
the no-primary ChIP samples (p , 0.05). At the Snrpn locus,
however, we did not see a signiﬁcant association when
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Author Summary
Genomic imprinting is a specialized system of gene regulation
whereby only one copy of a gene is used, either the maternal or the
paternal copy. Misregulation of imprinting in humans results in
developmental disorders such as Beckwith-Wiedemann Syndrome,
and is implicated in many cancers. Study of imprinted genes in mice
can lead to a greater understanding of these diseases as well as
insight into gene regulation. Many imprinted genes are associated
with methylation on the silenced allele. The imprinted gene H19 is
maternally expressed and paternally methylated in a region
upstream of the promoter known as the differentially methylated
domain. This region is required for proper imprinted expression of
H19 and its upstream imprinted neighbor Igf2. Our studies have
explored the requirement for methyl-CpG binding protein 3 (MBD3)
in silencing of the paternal allele. MBD3 is known to be part of a
repressive complex that resides at silenced genes. In our experi-
ments, we have shown that MBD3 is required for imprinting of H19,
and is also required for the maintenance of methylation on the
paternal allele. Finally, the MBD3 protein can be found at the
differentially methylated domain. The identification of a protein
required for silencing of the paternal allele of H19 is an important
step in understanding regulation of this gene.compared to the control samples (p ¼ 0.12). Although MBD3
was reported to be unable to bind directly to methylated
DNA because of amino acid substitutions in its MBD domain,
our results, along with MBD3 ChIP results at other loci [19,20]
suggest that MBD3 is associated with DNA at repressed loci.
Our data showing that MBD3 is expressed early during
development, along with these ChIP experiments that
demonstrate that MBD3 is bound at H19, provide compelling
Figure 1. Mbd3 RNA and Protein Patterns in Oocytes and Preimplantation Embryos
(A) Mbd3 and globin primers were used to amplify Mbd3 and exogenously added globin RNA from oocyte and preimplantation embryo cDNA samples.
Mbd3 RNA was normalized against exogenously added globin RNA.
(B) Immunocytochemistry using an anti-MBD3 antibody and a Cy3 secondary antibody showed that MBD3, a nuclear protein, is also maternally
contributed to oocytes and follows a pattern similar to that of Mbd3 RNA, increasing to high levels at the blastocyst stage.
(C) Chromatin immunoprecipitation (ChIP) from hybrid ES cells at the H19 DMD, Oct4, and Snrpn loci with acetylated H3 antibody (AcH3) (Lanes 3 and
10) and MBD3 antibody (Lanes 4, 7, and 11). The H19 DMD and Oct4 are precipitated with the MBD3 antibody. Input chromatin (Lanes 1, 5, and 8) and
no primary antibody (Lanes 2, 6, and 9) are included as positive and negative PCR controls. In the experiment presented here, 65% of the chromatin
associated with the MBD3 antibody was from the paternal allele (C).
(D) Quantitative real-time PCR was conducted using primers specific to the H19 DMD (i) or to the Snrpn imprinting control region (ii) for antibody-
precipitated samples and no primary antibody (No 1) controls. The average percentage (þ/  standard deviation) of bound material for three or more
chromatin preparations is shown. The AcH3 results were set at 100% and the other values were normalized to the AcH3 results. A significant enrichment
of MBD3 at the H19 DMD was evident when compared with the no-primary control (p , 0.05), but this enrichment was not observed at the Snrpn
imprinting control region (p ¼ 0.12). There was a significant enrichment for AcH3 histones at both loci (p , 0.01).
doi:10.1371/journal.pgen.0030137.g001
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preimplantation embryos.
Use of RNAi for Specific Knockdown of Mbd3 RNA and
Reduction in MBD3 Protein
To determine if MBD3 was required for imprinted gene
expression, we employed two RNAi approaches (injection and
TG RNAi) that reduce maternal stores of RNA, but could also
persist to reduce newly transcribed zygotic Mbd3 messages
(Figure 2A). In the ﬁrst method (injection RNAi), in vitro
transcribed dsRNA (dsMbd3 or control dsGfp) was injected
into one-cell embryos. Embryos were then cultured to the
blastocyst stage and collected for analysis. An additional
group of uninjected embryos was also cultured to control for
culture conditions. The second RNAi approach (TG RNAi)
utilized a transgene to reduce Mbd3 RNA levels. The
transgene employs the zona pellucida 3 (Zp3) promoter,
which drives expression of linked sequences in growing
oocytes [21]. The promoter is upstream of an Mbd3 inverted
repeat that generates an approximately 510-bp dsRNA that is
identical to that used for the injection RNAi experiments.
Both RNAi strategies resulted in reduced Mbd3 RNA and
protein levels. The RNA levels were examined by semi-
quantitative reverse transcriptase PCR (RT-PCR) and real-
time RT-PCR using Mbd3-speciﬁc primers and Gapdh primers
for normalization (Figure 2B and 2C). Injection RNAi
embryos were assessed at the blastocyst stage for RNA and
protein. On average, blastocysts used for these experiments
had only 35% of Mbd3 RNA compared to control embryos
(Figure 2B). RNAi-treated embryos were assayed for Mbd2
RNA levels (Figure 2D) as Mbd2 encodes the family member
that is most closely related to Mbd3 [22]. Mbd2 levels were
unchanged in the dsMbd3-injected embryos, demonstrating
that dsMbd3 is both effective and speciﬁc. RNAi-treated
blastocysts were also assayed by immunocytochemistry with
an anti-MBD3 antibody to determine protein levels at the
blastocyst stage. dsMbd3-injected embryos had very little
MBD3 protein compared to control embryos at the blastocyst
stage, demonstrating that the MBD3 protein is labile enough
to respond to dsRNA injection during this preimplantation
period (Figure 2E).
For the TG RNAi experiments, 11 TG lines were generated.
Each line was assessed for levels of Mbd3 RNA at the GV stage
of oogenesis, a time following the initiation of transgene
expression. The lines showed a range of RNAi efﬁcacy from
14% of control levels in the best line, line 37, (normalized to
Gapd and compared to nontransgenic (NTG) controls as
described above) to 100% of Mbd3 RNA in poor lines. The
experiments described here were conducted using line 37
(Figure 3C), the best line in terms of RNA and protein
depletion. Similar to the injection RNAi embryos, TG RNAi
embryos showed a severe reduction in MBD3 protein at the
blastocyst stage (Figure 2E). Together, these experiments
revealed that the RNAi that targets Mbd3 is effective in
reducing MBD3 protein levels when administered in the
growing oocyte or at the one-cell stage.
Loss of H19 Imprinted Gene Expression in RNAi-Treated
Embryos
With RNAi effectively and speciﬁcally reducing Mbd3 RNA
and protein during the preimplantation period, these
embryos could be used to determine if Mbd3 is required for
proper imprinted gene expression during this time. Only a
small group of imprinted genes, including the maternally
expressed H19 gene and the paternally expressed Snrpn gene,
are ﬁrst expressed and imprinted during the preimplantation
period. As H19 transcription commences at the late blastocyst
stage, blastocysts from both injection RNAi and TG RNAi
were examined for changes in expression from the normally
silent paternal allele. An allele-speciﬁc real-time RT-PCR
assay enables simultaneous examination of both parental
alleles, thereby allowing for an assessment of paternal allele
activation in single blastocysts [23]. In blastocysts derived
from injection of one-cell embryos with dsRNA, a quarter of
the embryos showed biallelic H19 expression whereas only
4% of uninjected blastocysts and no dsGFP-injected blasto-
cysts exhibited biallelic H19 expression (Figure 3). Blastocysts
from line 37 showed a similar but more robust effect; 40% of
blastocysts derived from TG mothers exhibited biallelic H19
expression whereas blastocysts from NTG mothers expressed
only the maternal H19 allele (Figure 3). In both sets of RNAi
experiments, the ratio of paternal expression to total H19
expression varied from 15%–55%. It should be noted that
although the imprinting of H19 is closely coordinated with
that of the linked and oppositely imprinted Igf2 gene,
expression of Igf2 is not evident until after implantation.
Thus, the role of MBD3 in the regulation of Igf2 could not be
assessed using this RNAi system. Nevertheless, these experi-
ments demonstrate that Mbd3 is required for proper
imprinted expression of H19 at the blastocyst stage.
RNAi-treated embryos were also assayed for the few other
imprinted genes expressed at this stage. All embryos were
assayed for Snrpn gene expression, but no change in Snrpn
imprinting was observed, consistent with the absence of
MBD3 binding in the Snrpn imprinting control region as
determined by ChIP (unpublished data). TG RNAi animals
were also assayed for Peg3, Gtl2, and Atp7a. Peg3 is an
imprinted gene on Chromosome 7 and is paternally ex-
pressed at the blastocyst stage (M. Mann and MSB, unpub-
lished data). Gtl2 is an imprinted gene on Chromosome 12
and is maternally expressed at the blastocyst stage [23]. Atp7a
is located on the X chromosome and is silenced on the
paternal allele due to imprinted X-inactivation in the
preimplantation embryo [24]. No changes in expression of
Peg3 and Gtl2 (in all embryos) and Atp7a (in female embryos)
were observed in TG embryos (unpublished data). These
results suggest that MBD3 protein is not required for all
imprinted gene expression at the blastocyst stage, and may
also indicate that the silent alleles at these loci employ other
MBD family members to confer silencing of the inactive
allele.
Loss of NuRD Repressive Complex with Reduction of
MBD3
Biochemical experiments indicate that MBD3 is an integral
member of the chromatin-remodeling complex Mi-2/NuRD,
and recent data suggest that in the absence of MBD3, this
complex is unstable [25]. To determine whether this complex
is intact in Mbd3 RNAi embryos, blastocysts from NTG
(Figure 4A) and TG mothers (Figure 4B) were stained with an
MTA-2-speciﬁc antibody. Consistent with the result seen with
Western blotting of MTA2 in Mbd3 null ES cells [25], Mbd3
RNAi TG blastocysts showed more than a 50% reduction in
average MTA-2 ﬂuorescence levels in blastocyst nuclei (Figure
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Loss of Imprinting in Mbd3 RNAi Embryos4C), a statistically signiﬁcant difference (p , 0.001). The
requirement for MBD3 for H19 imprinted expression and the
accompanying reduction in MTA-2 levels strongly implicates
a role for the Mi-2/NuRD complex in repression at this
imprinted locus.
Loss of H19 Methylation in Mbd3–Depleted Embryos
The relaxation of paternal H19 expression in Mbd3 RNAi
blastocysts suggested that there might be changes in DNA
methylation at the paternal DMD. To address this question,
several pools of ﬁve blastocysts from RNAi-treated animals
Figure 2. Mbd3 RNA and Protein Are Specifically Reduced in RNAi-Treated Embryos
(A) A schematic depicting the RNAi transgene showing the Zp3 promoter driving expression of Gfp and the Mbd3 inverted repeat in growing oocytes.
The dsRNA used in the injection RNAi experiments is designated by the red line below the inverted Mbd3 repeat and is identical to the sequence used in
the TG RNAi.
(B) RNA was collected from embryos injected with dsMbd3 [M], dsGfp [G], or uninjected [U], cultured for 96 h, and collected in pools of six blastocyst-
stage embryos. The RNA was used for quantitative RT-PCR. When normalized to Gapd RNA levels and compared to uninjected and dsGfp-injected
control embryos, dsMbd3-injected embryos show reduced levels of RNA. The embryos shown have only 24% of the Mbd3 RNA compared to uninjected
embryos. RNA from TG and NTG GV stage oocytes was also used for quantitative RT-PCR.
(C) A graphical representation of real-time quantitative RT-PCR experiments demonstrating reduced Mbd3 RNA levels in TG oocytes. TG and NTG bars
represent the ratios of Mbd3 to H2afy2 levels (a H2 histone expressed in early embryos) derived from crossing points. The ratios are normalized to the
levels in NTG embryos (shown as 1), and are the averages of three experiments. TG oocytes have only 15% of the Mbd3 RNA compared to NTG oocytes.
(D) RT-PCR analysis for Mbd2 demonstrates targeting specificity for Mbd3 because no reduction in Mbd2 mRNA was seen.
(E) Embryos were subjected to immunocytochemistry with the anti-MBD3 antibody as described in Figure 1B. MBD3 protein levels are greatly reduced
in both dsMbd3 injected embryos (iv) and TG embryos (viii) when compared to dsGfp injected (ii) and NTG (vi) controls. Embryos were also treated with
SytoX (i, iii) or DAPI (v, vii) to show the nuclei of the embryos. DsGfp injected embryos are shown in i, ii; dsMbd3 injected embryos are shown in iii, iv;
with NTG (v, vi) and TG blastocysts (vii, viii) shown in the bottom panels.
doi:10.1371/journal.pgen.0030137.g002
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the H19 DMD examined using bisulﬁte methylation assay.
After the pools were subjected to bisulﬁte mutagenesis, PCR
products were obtained from the 59 portion of the DMD,
cloned, and sequenced to determine the DNA methylation
status of individual DNA strands (Figure 5). C57BL/6
(maternal) and Mus musculus castaneus (paternal) DNA poly-
morphisms were used to distinguish the two parental alleles.
The 59 DMD contains 17 CpGs over 426 bp, and strands that
lacked nine or more methylated CpGs were considered
hypomethylated.
A reduced number of DNA methylated strands was seen in
at the H19 DMD in RNAi-treated embryos when compared to
controls. DsMbd3-injected embryos had 42% hypomethylated
paternal strands compared to 13% and 17% for uninjected
and dsGfp-injected controls, respectively (Figure 5). Similarly,
pools from TG RNAi embryos had 42% hypomethylated
paternal strands whereas NTG control pools contained only
16% hypomethylated paternal strands (Figure 5). A Snrpn
PCR product was also obtained from these embryos and
sequenced, but the normally methylated maternal alleles
from dsMbd3-treated embryos did not differ from controls
(unpublished data). These results suggest that MBD3 is
required to maintain the paternal methylation mark during
the preimplantation period at the H19 locus.
The absence of Mbd3 in preimplantation embryos leads to
both biallelic expression of H19 and loss of methylation at the
normally methylated paternal allele at the blastocyst stage.
Since the RNAi effect is transient, we analyzed later stage
embryos (7.5 days post coitus [dpc]) to determine if H19
expression and DNA methylation defects are maintained.
Both TG (n ¼ 7) and NTG (n ¼ 9) embryos expressed H19
exclusively from the maternal allele. Likewise, both TG and
NTG 7.5-dpc embryos exhibited a hypermethylated DMD on
the paternal allele. Presumably, Mbd3 RNA and protein levels
rise soon after the blastocyst stage. These results with later
embryos suggest that either reduction of Mbd3 mRNA and
protein has only a transient effect that can be repaired or
that embryos with serious imprinting problems fail to
develop further.
Mbd3 RNAi Blastocysts Have Fewer Cells Than Control
Embryos
During the course of these experiments, we noted that
some dsMbd3-injected blastocysts were smaller than both
uninjected and dsGfp-injected control blastocysts. To inves-
tigate this observation further, control and experimental
blastocysts were collected to determine if the Mbd3 RNAi
embryos had fewer cells. These experiments revealed that
RNAi embryos have signiﬁcantly fewer cells than control
embryos (Table 1). For injection RNAi, uninjected blastocysts
have an average of 97 cells, dsGFP injected embryos have an
average of 87 cells, and dsMbd3 RNAi blastocysts have an
average of 74 cells per embryo (p , 0.01). TG RNAi blastocysts
(77.5 cells) also have fewer cells than NTG control blastocysts
(93.8 cells; p , 0.05).
The dsMbd3 embryos did not appear grossly different from
control embryos other than the noticeable difference in size,
although the incidence of hatching of dsMbd3-treated
blastocysts was reduced (unpublished data). DAPI or propi-
dium iodide staining revealed the nuclei to be normal in size
and morphology and the blastocysts did not show any
evidence of increased apoptosis as determined by TUNEL
assay (unpublished data). The DAPI staining revealed that
Mbd3-injected RNAi embryos but not TG RNAi embryos have
Figure 3. H19 Is Derepressed at the Paternal Allele after Mbd3 RNAi
One-cell C57BL/6J X B6(CAST7) embryos were injected with dsRNA, cultured to the blastocyst stage, and collected singly for RNA extraction. Similarly,
TG and NTG embryos were either cultured as above or collected from mothers at 3.5 dpc. Real-time RT-PCR with allele-specific hybridization probes was
used to determine H19 expression from each allele, as shown in (A). Shown are the melting curves of the control samples along with a biallelic TG and
monoallelic TG sample (the melting curves for the ten other samples processed at the same time are omitted for clarity). The red curve is the melting
curve of a Cast control (probe melts off at 60 8C) and the green represents a C57BL/6J control (probe melts off at 65 8C). The grey curve is one of the
biallelic TG blastocysts, with two peaks corresponding to the paternal Cast allele and the maternal C57BL/6J allele. The blue curve is a TG sample that is
monoallelic for H19 (maternal C57BL/6J allele only). (B) H19 is biallelically expressed in 26% (9/35) of dsMbd3 injected embryos. This is significantly
different from controls (p , 0.01 compared to uninjected [2/46] and p , 0.01 compared to dsGfp injected [0/28]). Most control embryos (uninjected
and dsGfp) express only the maternal H19 allele. In the Zp3-dsMbd3 TG embryos, 40% (15/38) of TG embryos show biallelic expression of H19. None (0/5)
of the NTG controls showed biallelic expression.
doi:10.1371/journal.pgen.0030137.g003
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pairs (Table 1). RNAi-treated embryos were also assayed by
immunocytochemistry for expression of markers of the inner
cell mass (OCT4) and trophoblasts (TROMA-1). DsMbd3-
treated embryos showed expression of both of these markers
at the blastocyst stage, suggesting that RNAi blastocysts form
both of these tissue types at an appropriate time. Interest-
ingly, Kaji et al. saw analogous results with smaller 5.5-dpc
Mbd3  /  null embryos even though blastocysts were normal
size [26]. Given that the Mbd3 / embryos were derived from
Mbd3 þ/  parents, the null embryos had maternal stores of
MBD3 protein and RNA, which is lacking in our RNAi
embryos and which would support normal cell division longer
than RNAi-treated embryos. Together, these data indicate
that MBD3 is required for proper cell division timing during
development, but that eventually these embryos become
blastocysts with both inner cell mass and trophoblast cells.
Discussion
There are two times in development when the mammalian
genome undergoes demethylation [27,28]. The ﬁrst is during
primordial germ cell migration and colonization of the
genital ridge, when the entire genome, including imprinted
genes, is demethylated. The second time is during preim-
plantation development, when the majority of the genome
undergoes demethylation. Whereas the paternal genome
undergoes almost immediate, presumably active, demethyla-
tion after fertilization [29–32], the maternal genome is
demethylated gradually, due to a loss of maintenance DNA
methylation, during cleavage divisions [33]. Most methylated
sequences are demethylated during these two events, but
imprinting control regions escape this demethylation. Spe-
ciﬁcally, for the paternally methylated H19 DMD, this region
must survive the active demethylation and then stay
methylated in subsequent stages during passive demethyla-
tion [34,35]. How these processes occur has remained
completely unknown up to this point. We propose that
MBD3 is intimately involved in these processes at the H19
locus during preimplantation development.
We initiated our studies with MBD3 for several reasons: it is
expressed during this critical period of preimplantation
development, Mdb3 knockouts display an early embryonic
lethal phenotype [17], and MDB3 is associated with chromatin
at the H19 DMD (Figure 1C). Two RNAi approaches allowed
us to reduce Mbd3 RNA and protein from oocytes and
preimplantation mouse embryos. The RNAi strategy for
depleting target RNA has several advantages over traditional
gene targeting experiments: RNAi allows for (1) reduction in
maternal RNA and protein that persists in traditional
knockouts, (2) production of a hypomorphic allelic series,
and (3) easy use of hybrid strains for allelic gene expression
analysis.
Using two types of RNAi approaches—injection of dsRNA
and TG RNAi—we observe the same effects on the imprinted
expression and DNA methylation of H19. Both methods
proved effective at reducing Mbd3 RNA and protein. In RNAi
embryos, but not control embryos, H19 is biallelically
expressed in a signiﬁcant fraction of blastocysts examined
(40% of TG RNAi and 26% of injection RNAi blastocysts).
These results demonstrate that MBD3 is required for proper
imprinted expression of H19.
Our initial hypothesis was that an MBD would bind to the
methylated DMD and recruit repressive complexes to silence
the paternal allele, but it is important to note that MBD3 fails
to bind methylated substrates as assayed by in vitro DNA
binding assays, likely due to a phenylalanine instead of a
critical tyrosine in its MBD motif [22,36]. Whereas in vitro
experiments suggest that MBD3 does not bind directly to the
methylated DMD, our ChIP results indicate that MBD3 is
directly associated with chromatin at the H19 DMD. Similarly,
chromatin immunoprecipitation experiments demonstrate
that MBD3 interacts with the methylated maternal allele of
the imprinted gene Zrsr1 in adult mouse livers [20].
Furthermore, MBD3 is an integral member of the chroma-
tin-remodeling enzyme Mi-2/NuRD, and recent data suggest
that in the absence of MBD3, this complex is unstable [25].
The reduction of MTA-2 levels in Mbd3 RNAi embryos
suggests that the amount of repressive NuRD complexes is
reduced in RNAi embryos, and that in the absence of these
complexes, H19 can be expressed from the paternal allele.
These data suggest an important role for the NuRD complex
in imprinted gene expression. Given the previously described
genetic and biochemical interactions between MBD2 and
MBD3 [17,37], MBD2 may also have a role in imprinted gene
repression. However, Mbd2 /  embryos have been examined
and shown to have proper expression of several imprinted
Figure 4. The Mi-2/NuRD Complex Protein MTA2 Is Reduced in Mbd3
RNAi Blastocysts
(A, B) NTG (n ¼ 4) (A) and Mbd3 RNAi TG (n ¼ 16) (B) embryos were
subjected to immunocytochemistry with the anti-MTA2 antibody. When
Mbd3 is reduced in TG embryos, MTA2 protein is significantly reduced
(compare [A] to [B]).
(C) Measurement of mean nuclear fluorescence using ImageJ software of
confocal images shows that the mean fluorescence of TG embryos have
on average 47% of the nuclear fluorescent MTA2 signal compared to
NTG samples.
doi:10.1371/journal.pgen.0030137.g004
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neously levels of MBD3 and other MBDs should uncover any
such role for MBD2 that may have been compensated for by
the presence of MBD3.
Although H19 is biallelically expressed in a signiﬁcant
number of Mbd3 RNAi blastocysts, not all blastocysts exhibit
such a loss of imprinting. Likewise, the DMD is not
completely demethylated on every strand, although there
are strands that were completely demethylated (Figure 5).
There are several possible explanations for this result. First,
RNAi may not completely ablate MBD3 function. Quantiﬁ-
cation of RNA levels indicated a fairly robust reduction in
Mbd3 RNA levels (Figure 2), and a nearly complete loss of
protein, as determined by immunocytochemistry, but, with
the technology currently available, it is difﬁcult to determine
the effective loss of MBD3 at the level of chromatin, where it
presumably acts. Second, even if robust reduction of MBD3 is
attained, MBD3 is one of several family members that are
expressed in preimplantation embryos, and these other
family members might provide compensatory activity in the
absence of MBD3. Finally, the timescale of this experiment
may not provide adequate time for MBD3 protein to turn
over completely, and for the results of the RNA reduction by
RNAi to be completely realized.
We examined expression of a handful of other imprinted
genes in RNAi embryos, but none showed derepression of the
silent allele, suggesting that MBD3 is not involved in their
repression. In this case, other MBDs might be required for
their imprinted expression. Alternatively, the presence of
other MBDs might be sufﬁcient to compensate for the
reduction in MBD3 at these loci, but not at H19. By reducing
several MBDs in concert by RNAi, such compensatory
Figure 5. Reduction of Mbd3 in Embryos Results in a Loss of Methylation at the H19 DMD
One-cell C57BL/6J X B6(CAST7) embryos were injected with dsRNA, cultured to the blastocyst stage, and collected in pools of five blastocysts (top).
Similarly, TG and NTG embryos were isolated at the one-cell stage, cultured to the blastocyst stage, and collected in pools of five (bottom). Bisulfite
mutagenesis was performed on agarose-embedded pools of five blastocysts. CpGs (17) were assayed in the 59 half of the DMD as indicated by the black
line in the diagram in the center. Each line of circles represents a single DNA strand with the number to the left of the line corresponding to the number
of times this pattern was seen. Each circle represents a single CpG. If the CpG was methylated, the circle is filled. Those strands with less than half of the
CpGs methylated are considered hypomethylated. In control embryos, only a few hypomethylated strands are recovered (13% and 17% for uninjected
and dsGFP-injected blastocysts, respectively), but in dsMbd3-injected embryos, 42% of the paternal strands are hypomethylated. TG RNAi blastocysts
showed similar results with 42% of the paternal strands hypomethylated compared to 16% of the strands in NTG embryos. Only paternal strands are
shown, as all sequenced maternal strands were unmethylated as expected. Although its expression also depends on the DMD, Igf2 is not expressed at
this stage.
doi:10.1371/journal.pgen.0030137.g005
Table 1. Cell Numbers of Blastocysts Following RNAi
Treatment Average
Cell
Number
Metaphase
Chromosome
Pairs
Number of
Embryos
Analyzed
Uninjected 97 2.3 23
dsEgfp 87.7 2.0 24
dsMbd3 74
a 3.3
a 27
NTG 93.8 3.5 19
TG 77.5
b 3.9 22
aSignificantly different from either uninjected or dsGfp-injected embryos (p , 0.01).
bSignificantly different from NTG embryos (p , 0.05)
doi:10.1371/journal.pgen.0030137.t001
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sensitive to perturbation of imprinting cofactors and the
paternal allele may be derepressed with the slightest insult to
the repressive complex, whereas other imprinted genes may
be able to make do with reduced MBD3 protein. Other types
of experiments with longer-lived effects such as knockout
alleles might be better suited to uncovering these effects as
well as determining if MBD3 is required for the imprinting of
genes such as Igf2 that are expressed later in development.
Finally, the continued discovery of new proteins with an
afﬁnity for methylated DNA might eventually uncover
different mechanisms for the recognition and silencing of
methylated sequences.
Our data suggest that MBD3 is required for maintenance of
DNA methylation at the H19 DMD during preimplantation
development. Similar to the result in which a portion of
embryos exhibit biallelic expression, a signiﬁcant fraction of
DNA strands are demethylated. For the reasons outlined
above, the loss of MBD3 at this locus may not be complete or
its effects may not be complete at the blastocyst stage. The
partial loss of DNA methylation and accompanying loss of
repression at H19 suggests there may be a threshold for DNA
methylation loss and concomitant paternal expression of
H19. Indeed, the percentage of hypomethylated strands is
similar to the number of embryos with biallelic expression of
H19. Our data reporting loss of methylation at the H19 DMD
in the absence of MBD3 uncovers a new role for MBD
proteins: protection of methylated regulatory sequences from
DNA demethylation during preimplantation development.
This role may not have been predicted by the MBD3 protein
sequence, but it is clear that methylated imprinted regions
must both be recognized and maintain their parental marks
during this developmental time period. It is an interesting
ﬁnding that a repressive complex that recognizes a differ-
entially methylated region would also be responsible for
maintaining that difference during development.
In conclusion, development of embryos that lack MBD3 is
perturbed, whether MBD3 is removed transiently by RNAi
(this study) or by a traditional deletion of the Mbd3 locus [17].
In the RNAi experiments, imprinted H19 expression is
disturbed along with loss in DNA methylation on the paternal
allele. In addition, the Mbd3 RNAi blastocysts are smaller and
slower to hatch than controls, suggesting delays in develop-
ment and perturbed cell cycles. Mbd3  /  animals die during
the peri-implantation period, but the phenotype had not
been extensively described until recently [17,26]. Kaji et al.
(2006) reported that Mbd3 / ES cells did not exhibit any cell
cycle delay when the ES cells were examined by ﬂow
cytometry [25], but that 5.5-dpc embryos have reduced cell
numbers [26]. These results suggest that the smaller Mbd3
RNAi embryos may be due to a developmental timing defect
rather than a cell-cycle delay. TUNEL assays did not detect an
increase in the number of cells undergoing apoptosis between
RNAi embryos and controls, suggesting that RNAi embryos
are not smaller due to increased cell death (unpublished
data). Furthermore, both inner cell mass and trophoblast cells
are present, suggesting no defects in the ﬁrst preimplantation
lineage decisions. Consistent with delays in cell division that
we observe, cells deﬁcient for Hells, a member of the SNF2
family of chromatin remodelers that is also a global regulator
of DNA methylation, have defects in DNA methylation and
are slow in completing mitosis [38]. Thus, the hypomethyla-
tion observed in Mbd3 RNAi embryos might similarly lead to
problems in cell division in embryos that may not be observed
in cultured ES cells. Finally, in both our study and in the
studies of Mbd3 / ES cells, loss of Mbd3 negatively affects the
Mi-2/NuRD complex [25]. Consequently, even a transient
MBD3 loss could lead to a global disruption of silencing
carried out by this complex beyond the perturbation we
report at the H19 locus. A microarray analysis of global
transcript proﬁles might uncover more genes regulated by
this complex or genes speciﬁcally responsible for the other
phenotypes we see beyond imprinting defects. Our results,
thus, uncover an essential role for MBD3, and the Mi-2/NuRD
complex, in regulating the imprinted H19 locus, and provide
tools to explore additional roles for MBD3 in genome-wide
transcriptional regulation.
Materials and Methods
Mice. For dsRNA injections, oocytes and embryos were obtained
from either CF1 (Harlan, http://www.harlan.com/) females mated to
CF1 males (for embryo assays) or from C57BL/6J (The Jackson
Laboratory, http://www.jax.org/) females mated to B6(CAST7) males
(for allelic assays) [23]. Embryos from TG animals were obtained by
mating TG females to B6(CAST7) or to B6(CAST7P12X) males. This
latter strain has Mus musculus castaneus Chromosomes 7, 12, and X in a
C57BL/6 background (M. Mann, J. Mager, C. Krapp, and MSB,
unpublished data). All experiments were conducted with the approval
of the Institutional Animal Care and Use Committee at the University
of Pennsylvania.
Production of dsRNA. Primers KR1 (59-CTATGGAGCGGAA-
GAGGTGGGA-39) and KR3 (59-CAGGCCCACTCCCTGCAGGC-39)
were used to amplify a 510-bp fragment corresponding to bp 1 to 510
of Mbd3 with Ready-to-Go PCR beads (Amersham http://www.
amersham.com/) from ES cell cDNA. PCR was performed for one
cycle of 94 8C for 2 min followed by 35 cycles of 15 s at 94 8C, 10 s at
55 8C, and 15 s at 72 8C, and one cycle of 72 8C for 15 min. The PCR
product was cloned using the Gateway BP reaction (Invitrogen, http://
www.invitrogen.com/) into the pDONR201 vector to give the pKR3.03
entry clone. This plasmid was combined in a Gateway LR reaction
with the L4440 Gateway C plasmid that contains two T7 promoters
ﬂanking the recombination sites to give pKR3.04. For in vitro
transcription, pKR3.04 was used as a template for PCR with primers
L4440F (59-AGCCGAACGACCGAGCGC-39)a n dL 4 4 4 0 R( 5 9-
TGCAAGGCGATTAAGTTG-39) that ﬂank the T7 promoters. The
PCR product was used as a template for a single T7 reaction that
produces both sense and antisense RNA. For in vitro transcription of
Gfp,aNotI- HindIII fragment from pEGFPN-2 (Clontech, http://www.
clontech.com/) was also cloned into the L4440 Gateway C plasmid.
Each 100-ll in vitro transcription reaction contained 5–10 lg of PCR
template, 13 T7 transcription buffer, 30 mM rNTPs, and T7 enzyme
mix (RiboMAX T7; Promega, http://www.promega.com/). Samples
were incubated at 37 8C for 2 h, after which the template was
digested with RQ1 RNase-free DNaseI (Promega) for 15 min at 37 8C.
Enzymes were removed with two phenol:chloroform:isoamyl alcohol
(25:24:1) and two chloroform:isoamyl alcohol (24:1) extractions and
RNA was recovered from the aqueous phase by two ethanol
precipitations with 1/10 volume of 10 M ammonium acetate. The
dsRNA was resuspended in 100 ll of RNase-free H2O, and its
concentration was estimated on a 1% agarose gel by comparing to a
mass ladder standard (Invitrogen).
dsRNA injections. Oocytes and preimplantation embryos from
CF1 or C57BL/6J mothers were microinjected with approximately 10
pl of 0.25 lg/ll dsRNA. Oocytes were cultured in CZB medium for 24
ha t3 78C in an atmosphere of 5% CO2. One-cell embryos were
isolated at 0.5 dpc and cultured to the blastocyst stage (96 h) in KSOM
with amino acids (KSOMþAA) at 37 8C in an atmosphere of 5% CO2,
5% O2, and 90% N2 [39]. DsGFP-injected and uninjected control
embryos were cultured alongside dsMbd3-injected embryos to
control for culture conditions.
TG mice. To generate the Zp3-dsMbd3 TG construct, an inverted
repeat was cloned into pRNAi-Zp3–1 [40]. First, primers KR1 and
KR3 were used to generate a 510-bp PCR fragment that was cloned
into pCR2.1 using the TOPO TA kit (pKR3.18). The inverted repeat
was generated by excising an XhoI–XbaI Mbd3 fragment from
pKR3.03, and ligating it into XhoI- and XbaI-digested pKR3.18,
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repeat was then excised with SpeI and ligated into pRNAi-Zp3–1 that
had been digested with XbaI, to give pMoZp3-dsMbd3.
TG animals were generated as previously described [41]. Animals
were genotyped by PCR assay for Gfp as previously described using
DNA isolated from tail or ear clippings as previously described [21].
This was conﬁrmed by Southern blot using a Gfp probe (unpublished
data). TG lines were maintained on a C57BL/6J background. Line 37
Mbd3 RNAi TG females described in this study are fertile.
Isolation of germinal vesicle stage oocytes and preimplantation
embryos. Germinal vesicle (GV) stage oocytes were isolated from
females at least 6 wk of age, as previously described [21]. For later-
stage embryos, females, at least 6 wk of age, were superovulated by
injection of 7.5 IU of pregnant mare serum gonadotropin (Calbio-
chem, http://www.emdbiosciences.com/) and 44–48 h after injection,
injected with 5.0 IU of human chorionic gonadotropin (hCG) and set
up for matings with stud males; females were checked for copulatory
plugs the following morning (0.5 dpc). Fertilized zygotes were
collected at 0.5 dpc, two-cell embryos at 1.5 dpc, and blastocysts at
3.5 dpc. Embryos were isolated in phosphate-buffered saline
containing 3 mg/ml polyvinylpyrrolidone (PBS/PVP, Calbiochem).
For isolation of RNA, embryos were transferred to 100 ll of lysis
buffer (Dynal, http://www.invitrogen.com/). Embryos used for bisulﬁte
mutagenesis were transferred in several microliters of PBS/PVP to a
1.5-ml tube. One-cell embryos were cultured to the blastocyst stage in
KSOM þ AA as described above.
RNA isolation, reverse transcription, and PCR. Poly-A
þmRNA was
isolated from oocytes and preimplantation embryos using the
Dynabead RNA Isolation Kit (Dynal) according to manufacturer’s
instructions and reverse transcribed for 60 min at 42 8C followed by
10 min at 95 8C as described previously [23].
All PCRs were carried out using Ready-to-go-PCR beads in a ﬁnal
volume of 25 ll and included 0.1 lCi of [a-
32P]-dCTP (New
England Nuclear [NEN], http://las.perkinelmer.com/). The reaction
conditions were such that the amount of product was in the linear
region of semi-log plots of the amount of product versus cycle
number [42]. Mbd3 was ampliﬁed from 1.5 oocyte (or blastocyst)
equivalents using a ﬁnal concentration of 0.6 lM of each primer,
KR15 (59-TGTCAGCCATTGCGAGTGCTC-39) and KR18 (59-CTA-
CACTCGCTCTGGCTCCGG3–39). These primers span an intron.
Mbd3 PCR was carried out for one cycle of 94 8C for 2 min followed
by 27 cycles for oocytes (25 cycles for blastocysts) of 15 s at 94 8C, 10 s
at 63 8C, and 20 s at 72 8C. Gapd was ampliﬁed from 0.5 oocyte (or
blastocyst) equivalents as described previously [21]. Samples for
developmental proﬁles were spiked with 0.125 pg/embryo equivalent
of rabbit a-globin (Invitrogen). Rabbit a-globin was ampliﬁed from
0.5 oocyte equivalents as described previously [43]. Mbd3 and Gapd
were ampliﬁed from the same samples to determine efﬁcacy of RNAi
treatments using cycle numbers in the linear range for each as
described above. The Mbd3 levels were then normalized to Gapd
levels from the same samples. Quantiﬁcation was performed using the
ImageQuant 5.2 program (Molecular Dynamics, http://www6.
gelifesciences.com/). Results with TG RNAi samples were conﬁrmed
by real-time RT-PCR using the Mbd3 and H2afy3 light cycler primers
(Table S1) using sequence-speciﬁc detection probes (Universal Probe
Library; Roche, http://www.roche.com/) as described by the manufac-
turer on a LightCycler Instrument (Roche).
Allele-speciﬁc expression analysis of blastocyst stage embryos. H19
and Snrpn expression assays were conducted on cDNA using the
LightCycler Real Time PCR System (Roche Molecular Biochemicals)
as described [23,44]. Gtl2 and Peg3 RT-PCR expression assays were
conducted on cDNA from single blastocysts and included 0.1 lCi of
[a-
32P]-dCTP (NEN). The data were quantiﬁed by phosphorimager
analysis following allelic restriction digests [44].
Immunoﬂuorescence. Oocytes or preimplantation embryos were
ﬁxed in 3.7% paraformaldehyde, pH 7.5, for 60 min at room
temperature or overnight at 4 8C, washed two to three times in PBS/
PVP, and stored at 4 8C in PBS/PVP. For staining, samples were
permeabilized for 15 min in freshly prepared PBS containing 0.25%
Triton-X100, washed three times in PBS/PVP, then blocked for 1 h in
5% donkey serum/0.1% ﬁsh gelatin/0.2% Tween-20/PBS. Samples
were then incubated overnight with polyclonal goat antibody against
an MBD3 peptide found in both mouse and human MBD3 (Santa
Cruz Biotechnology, http://www.scbt.com/) diluted 1:50 in blocking
solution. The speciﬁcity of the antibody was conﬁrmed by loss of
nuclear signal after blocking with the peptide the antibody was raised
against (Santa Cruz Biotechnology) and further validated by the
presence of a 34-kDa band on a Western blot of HeLa cell extracts.
Blastocysts contain too little protein for visualization of MBD3 or
MTA-2 by Western blotting. After three 15 min washes in 0.2%
Tween-20/PBS, samples were transferred to a 1:500 dilution of donkey
Cy3-conjugated anti-goat IgG (Jackson ImmunoResearch Laborato-
ries, http://www.jacksonimmuno.com/) and 2 lg/ml DAPI (Sigma,
http://www.sigmaaldrich.com/) in blocking solution for 60 min.
Samples were washed three times for 15 min. Blastocysts were
equilibrated in increasing amounts of Vectashield (Vector, http://
www.vectorlabs.com/) to maintain shape and maximal ﬂuorescence.
Finally, oocytes or embryos were mounted on a glass slide and
visualized with a confocal microscope (Leica, http://www.leica.com/).
All incubations were at room temperature unless otherwise noted. In
order to count nuclei, z-stacks of the confocal images through each
blastocyst were collected, with 2.5 lm between each z-plane. Stacks
were assembled into movies in NIHImage (http://rsb.info.nih.gov/
nih-image/), and nuclei were counted manually in each plane, taking
care to note which nuclei had been counted in the previous plane. To
determine mean ﬂuorescence, ImageJ (http://rsb.info.nih.gov/ij/) was
used to draw a region of interest inside each of ﬁve nuclei per embryo
in the middle slice of confocal stacks and to measure the mean pixel
intensity in the region. The values for TG and NTG embryos were
averaged and graphed in Excel (http://ofﬁce.microsoft.com/) to obtain
the data in Figure 4.
Southern analysis. Ten micrograms of isolated DNA were digested
with StuI, separated on a 0.8% agarose gel, transferred to a nylon
membrane, and probed as previously described [41]. The Gfp probe
fragment was isolated from pEGFP-N1 (Clontech) and labeled
with [a-
32P]-dCTP (NEN). Blots were analyzed using a Phosphor-
imager (Molecular Dynamics).
Bisulﬁte mutagenesis. Pools of ﬁve blastocysts were embedded in
approximately 10 ll of molten 2% low-melting point SeaPlaque
agarose (BioWhittaker Molecular Applications, http://www.
lonzabioscience.com/), and treated as previously described [21]. To
prepare DNA for PCR, pellets were resuspended in an appropriate
amount of water, and melted 5 min ﬁrst at 65 8C and then at 80 8C.
Blastocyst equivalents (2.5) of the mutagenized DNA were used for
each PCR and products were cloned and sequenced as described
previously [21]. Six or more clones were sequenced for each PCR.
Strands from a PCR that contained an identical pattern of
methylated CpGs and that could not be distinguished from other
strands by polymorphisms were only counted once.
Chromatin immunoprecipitation assays. ChIP assays were carried
out using the Chromatin Immunoprecipitation Assay Kit (Upstate,
http://www.upstate.com/) according to the manufacturer’s instruc-
tions, with a few modiﬁcations. The ES cells used in these experi-
ments were derived from blastocysts generated from crosses between
C57BL/6 (B6) female mice and B6(CAST7P12X) male mice. The ES
cells were grown on MEF feeder layers in 60-mm dishes, trypsinized,
and replated on gelatinized plates to allow MEFs to attach for 1 h. The
supernatants containing the ES cells were then collected in 50-ml
conical tubes, crosslinked with 1% formaldehyde (Sigma) for 15 min
at room temperature, and then the reaction was quenched with
0.125 M glycine for 5 min at room temperature. Following lysis,
sonication was carried out using a Branson Soniﬁer 250 (http://www.
soniﬁer.com/) at 30% output for four pulses of 10 s each. The
sonicated cell supernatant was diluted 10-fold in ChIP dilution buffer
(Upstate) and 1% of material was removed prior to the addition of
antibodies (input). 80–100 lg of chromatin was used for each
immunoprecipitation reaction with the following antibodies: anti-
acetyl-Histone H3 (06–599; Upstate) and anti-MBD3 (ab3755; abcam,
http://www.abcam.com/) [18,20]. For the ﬁnal step, samples were
resuspended in 30 ll of TE and 1 ll was used for each PCR. Input
DNAs were diluted 10-fold. Three separate ChIP experiments were
performed with the antibodies described.
Allele-speciﬁc ChIP PCRs. For allele-speciﬁc analysis, input and
immunoprecipitation DNAs were ampliﬁed with primers speciﬁc to
different regions at H19, Snrpn, and Oct4 (see Table S1). Brieﬂy, all
PCRs were carried out with Ready-To-Go PCR beads (Amersham)
using 0.3 lM of each primer and 0.1 lCi of [
32P]-dCTP. A fraction of
the PCR was used for each digest (see Table S1). Products were
resolved on 7% polyacrylamide gels and the relative band intensities
were quantiﬁed using ImageQuant (Molecular Dynamics). Real time
PCR analysis was carried out on the ChIP samples using the
LightCycler Real Time PCR System (Roche) to quantitatively assess
the amount of chromatin bound in each ChIP experiment, and to
determine the linear range of each ChIP PCR (unpublished data).
Brieﬂy, reactions were set up in triplicate using the Ready-To-Go
PCR beads (Amersham), with a 5-min initial incubation with the
TaqStart antibody (Clontech), followed by addition of 0.3 lM primers
(see Table S1), 13 SYBR Green (Roche), and 1.5–3.0 mM MgCl2. Data
analysis was performed using the Light Cycler version 4.0 software
(Roche).
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Loss of Imprinting in Mbd3 RNAi EmbryosStatistical analysis. Statistical values for each dataset, with the
exception of the ChIP data, were determined by the Fisher exact test
using the GraphPad Prism statistics software suite (http://www.
graphpad.com/prism/). For the ChIP data, average percentages (and
standard deviations) of bound material for the ChIP experiments
were calculated, and these means were statistically compared using a
one-tailed t-test.
Supporting Information
Table S1. Primers and Conditions for PCR Analysis
Found at doi:10.1371/journal.pgen.0030137.st001 (37 KB DOC).
Accession Number
The National Center for Biotechnology Information (NCBI)
GenBank (http://www.ncbi.nlm.nih.gov/sites/entrez?db¼Nucleotide)
accession number for Mbd3 is AF120995.
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